Allmed Solutions Ltd (ALMD) - Net Assets
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has net assets worth ILA28.07 Million ILA (≈ $75.25K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA31.54 Million ≈ $84.57K USD) and total liabilities (ILA3.48 Million ≈ $9.32K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALMD asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA28.07 Million |
| % of Total Assets | 88.98% |
| Annual Growth Rate | 4.1% |
| 5-Year Change | -46.34% |
| 10-Year Change | -26.51% |
| Growth Volatility | 59.4 |
Allmed Solutions Ltd - Net Assets Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's net assets have evolved over time, based on quarterly financial data. Also explore ALMD total assets for the complete picture of this company's asset base.
Annual Net Assets for Allmed Solutions Ltd (2008–2025)
The table below shows the annual net assets of Allmed Solutions Ltd from 2008 to 2025. For live valuation and market cap data, see Allmed Solutions Ltd (ALMD) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ILA28.07 Million ≈ $75.25K |
-33.20% |
| 2024-12-31 | ILA42.02 Million ≈ $112.65K |
-24.93% |
| 2023-12-31 | ILA55.97 Million ≈ $150.06K |
+3.73% |
| 2022-12-31 | ILA53.96 Million ≈ $144.67K |
+3.15% |
| 2021-12-31 | ILA52.31 Million ≈ $140.25K |
+7.26% |
| 2020-12-31 | ILA48.77 Million ≈ $130.76K |
-13.80% |
| 2019-12-31 | ILA56.58 Million ≈ $151.69K |
+72.33% |
| 2018-12-31 | ILA32.83 Million ≈ $88.02K |
-15.28% |
| 2017-12-31 | ILA38.76 Million ≈ $103.91K |
+1.48% |
| 2016-12-31 | ILA38.19 Million ≈ $102.39K |
-15.37% |
| 2015-12-31 | ILA45.13 Million ≈ $120.98K |
+40.32% |
| 2014-12-31 | ILA32.16 Million ≈ $86.22K |
+6.41% |
| 2013-12-31 | ILA30.22 Million ≈ $81.02K |
-55.09% |
| 2012-12-31 | ILA67.29 Million ≈ $180.40K |
-7.00% |
| 2011-12-31 | ILA72.36 Million ≈ $193.98K |
+175.25% |
| 2010-12-31 | ILA26.29 Million ≈ $70.47K |
+142.70% |
| 2009-12-31 | ILA10.83 Million ≈ $29.04K |
-23.66% |
| 2008-12-31 | ILA14.19 Million ≈ $38.04K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Allmed Solutions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 23692600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA19.22 Million | 76.13% |
| Other Components | ILA256.24 Million | 1015.02% |
| Total Equity | ILA25.25 Million | 100.00% |
Allmed Solutions Ltd Competitors by Market Cap
The table below lists competitors of Allmed Solutions Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TIMES CHINA HLDGS HD -10
F:T2H
|
$8.53 Million |
|
IL&FS Transportation Networks Limited
NSE:IL&FSTRANS
|
$8.54 Million |
|
Energy Development Company Limited
NSE:ENERGYDEV
|
$8.54 Million |
|
FATFISH GROUP LTD.
F:1JU
|
$8.54 Million |
|
Oncosil Medical Ltd
AU:OSL
|
$8.52 Million |
|
Touchwood Entertainment Limited
NSE:TOUCHWOOD
|
$8.52 Million |
|
Yelooo Integra Datanet Tbk PT
JK:YELO
|
$8.52 Million |
|
Orestone Mining Corp
V:ORS
|
$8.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Allmed Solutions Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 39,307,000 to 25,245,000, a change of -14,062,000 (-35.8%).
- Net loss of 14,124,000 reduced equity.
- Other comprehensive income decreased equity by 12,305,000.
- Other factors increased equity by 12,367,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-14.12 Million | -55.95% |
| Other Comprehensive Income | ILA-12.30 Million | -48.74% |
| Other Changes | ILA12.37 Million | +48.99% |
| Total Change | ILA- | -35.77% |
Book Value vs Market Value Analysis
This analysis compares Allmed Solutions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.11x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.38x to 13.11x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | ILA7.56 | ILA33.10 | x |
| 2012-12-31 | ILA7.90 | ILA33.10 | x |
| 2013-12-31 | ILA3.05 | ILA33.10 | x |
| 2014-12-31 | ILA1.75 | ILA33.10 | x |
| 2015-12-31 | ILA1.58 | ILA33.10 | x |
| 2016-12-31 | ILA0.85 | ILA33.10 | x |
| 2017-12-31 | ILA0.66 | ILA33.10 | x |
| 2018-12-31 | ILA0.45 | ILA33.10 | x |
| 2019-12-31 | ILA0.72 | ILA33.10 | x |
| 2020-12-31 | ILA0.61 | ILA33.10 | x |
| 2021-12-31 | ILA0.63 | ILA33.10 | x |
| 2022-12-31 | ILA0.64 | ILA33.10 | x |
| 2023-12-31 | ILA0.66 | ILA33.10 | x |
| 2024-12-31 | ILA0.46 | ILA33.10 | x |
| 2025-12-31 | ILA2.52 | ILA33.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Allmed Solutions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -55.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.25x
- Recent ROE (-55.95%) is below the historical average (-40.14%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -44.58% | 0.00% | 0.00x | 1.09x | ILA-7.74 Million |
| 2009 | -35.78% | 0.00% | 0.00x | 1.06x | ILA-4.96 Million |
| 2010 | -35.72% | -1980.80% | 0.01x | 1.36x | ILA-12.02 Million |
| 2011 | -19.44% | -548.85% | 0.03x | 1.10x | ILA-21.30 Million |
| 2012 | -44.27% | -1116.04% | 0.03x | 1.20x | ILA-36.52 Million |
| 2013 | -165.46% | -1063.71% | 0.11x | 1.44x | ILA-53.03 Million |
| 2014 | -76.63% | -501.30% | 0.11x | 1.39x | ILA-27.86 Million |
| 2015 | -46.38% | -404.25% | 0.09x | 1.26x | ILA-25.44 Million |
| 2016 | -62.62% | -325.27% | 0.14x | 1.37x | ILA-27.74 Million |
| 2017 | -58.98% | -294.42% | 0.15x | 1.35x | ILA-26.52 Million |
| 2018 | -61.64% | -217.43% | 0.22x | 1.32x | ILA-23.45 Million |
| 2019 | 38.33% | 197.25% | 0.17x | 1.17x | ILA16.25 Million |
| 2020 | -17.70% | -89.08% | 0.17x | 1.15x | ILA-13.55 Million |
| 2021 | 5.57% | 50.64% | 0.10x | 1.09x | ILA-2.23 Million |
| 2022 | -21.73% | 0.00% | 0.00x | 1.12x | ILA-16.34 Million |
| 2023 | 2.66% | 0.00% | 0.00x | 1.11x | ILA-3.92 Million |
| 2024 | -22.27% | 0.00% | 0.00x | 1.14x | ILA-12.68 Million |
| 2025 | -55.95% | 0.00% | 0.00x | 1.25x | ILA-16.65 Million |
Industry Comparison
This section compares Allmed Solutions Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $113,471,667
- Average return on equity (ROE) among peers: -24.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Allmed Solutions Ltd (ALMD) | ILA28.07 Million | -44.58% | 0.12x | $8.53 Million |
| Erika Carmel Ltd (BCUR) | $88.06 Million | -24.76% | 0.42x | $4.69 Million |
| Bio-View Ltd (BIOV) | $18.18 Million | 11.59% | 0.71x | $4.83 Million |
| Brainsway Ltd (BWAY) | $57.32 Million | -11.27% | 0.32x | $463.07 Million |
| Erech Finance Cahalacha Ltd (EFNC) | $28.37 Million | -88.27% | 1.44x | $1.74 Million |
| Epitomee Medical Ltd (EPIT) | $39.45 Million | -39.02% | 0.40x | $62.09 Million |
| Erika Carmel-Tech Ltd (ERKA) | $88.06 Million | -24.76% | 0.42x | $5.82 Million |
| Human Xtensions Ltd (HUMX) | $104.53 Million | -51.30% | 0.15x | $2.12 Million |
| Ilex Medical (ILX) | $443.54 Million | 27.20% | 0.76x | $141.31 Million |
| Pulsenmore Ltd (PULS) | $153.73 Million | -16.67% | 0.09x | $22.89 Million |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more